Lymphadenectomy in elderly patients with high-intermediate-risk, high-risk or advanced endometrial cancer: Time to move from personalized cancer medicine to personalized patient medicine!

被引：9

作者：

Racin, Adelaide ^{[1
]}

Raimond, Emilie ^{[2
]}

Bendifallah, Sofiane ^{[3
,4
]}

Timoh, Krystel Nyangoh ^{[1
]}

Ouldamer, Lobna ^{[5
]}

Canlorbe, Geoffroy ^{[4
]}

Hudry, Nina ^{[6
]}

Coutant, Charles ^{[6
]}

Graesslin, Olivier ^{[5
]}

Touboul, Cyril ^{[7
]}

Collinet, Pierre ^{[8
]}

Bricou, Alexandre ^{[9
]}

Huchon, Cyrille ^{[7
,10
]}

Koskas, Martin ^{[11
]}

Ballester, Marcos ^{[2
,12
]}

Darai, Emile ^{[2
,12
]}

Leveque, Jean ^{[1
]}

Lavoue, Vincent ^{[1
]}

机构：

[1] Univ Rennes 1, CHU Rennes, Serv Gynecol,CLCC Eugene Marquis, Hop Sud,U1242,Chem Oncogenesis Stress & Signaling, 16 Bd Bulgarie, F-35000 Rennes, France

[2] Inst Alix Champagne Univ Hosp, Dept Obstet & Gynaecol, Reims, France

[3] Univ Paris 06, Tenon Univ Hosp, AP HP, Dept Gynaecol & Obstet,IUC, Paris 6, France

[4] Univ Paris 06, INSERM UMR S 707, Epidemiol Informat Syst Modeling, Paris 6, France

[5] Ctr Hosp Reg Univ Tours, Dept Obstet & Gynaecol, Hop Bretonneau, Tours, France

[6] Ctr Lutte Canc Georges Francois Leclerc, Dijon, France

[7] Ctr Hosp Intercommunal, Dept Obstet & Gynaecol, Creteil, France

[8] Ctr Hosp Reg Univ, Dept Obstet & Gynaecol, Lille, France

[9] Univ Paris 13, Jean Verdier Univ Hosp, AP HP, Dept Gynaecol & Obstet, Paris, France

[10] Ctr Hosp Intercommunal, Dept Gynaecol & Obstet, Poissy, France

[11] Hop Xavier Bichat, AP HP, Dept Gynaecol & Obstet, Paris, France

[12] Univ Paris 06, INSERM UMR S 938, Paris 6, France

来源：

EJSO | 2019年 / 45卷 / 08期

关键词：

High-risk endometrial cancer; Elderly; Surgery; Lymphadenectomy; Cancer-specific survival; SENTINEL-NODE BIOPSY; QUALITY-OF-LIFE; ROBOTIC SURGERY; WOMEN; MANAGEMENT; OLDER; AGE; STAGE; MULTICENTER; OUTCOMES;

D O I：

10.1016/j.ejso.2019.02.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Pelvic and paraaortic lymphadenectomy are recommended for women with high-intermediate, high-risk and advanced endometrial cancer (EC). Lymphadenectomy is less frequently performed in elderly patients than in younger patients. We examined the survival of elderly women diagnosed with high-risk EC according to whether lymphadenectomy was performed or not. Methods: We selected women over 70 years with high-intermediate risk, high-risk or advanced EC from a multicenter retrospective cohort of women diagnosed between 2001 and 2013. Multivariate logistic regression models and Cox proportional hazards survival methods for overall survival (OS), disease-free survival (DFS) and cancer-specific survival (CSS) were used for analyses. Results: 71 women had lymphadenectomy and were compared with the 213 who did not. Recurrence was similar in both groups (42% vs 33%, respectively, p = 0.17) but more deaths were reported in the group without lymphadenectomy (38% vs 23%, respectively, p < 0.001). There was no difference in adjuvant treatment in the two groups (17% vs 27%, respectively, p = 0.27). Elderly patients without lymphadenectomy had lower 3-year DFS (56% vs 71%, p = 0.076), CSS (67% vs 85%, p < 0.001) and OS (50% vs 71% p < 0.001). The Cox proportional hazard models showed independently poorer prognosis in women without lymphadenectomy (3.027, 95% CI 1.58-5.81, p < 0.001), histology type 2 (3.46, 95% CI 1.51-7.97, p = 0.003) and lymphovascular space involvement (3.47, 95% CI 1.35-8.98, p = 0.01) on 3-year CSS. Conclusion: No lymphadenectomy in elderly patients with high-risk or advanced EC is independently associated with poorer prognosis. Elderly patients with EC should benefit from lymphadenectomy when indicated. (C) 2019 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

引用

页码：1388 / 1395

页数：8

共 50 条

[21] Factors Predictive of Receiving Adjuvant Radiotherapy in High-Intermediate-Risk Stage I Endometrial Cancer
McGunigal, Mary
Pollock, Ariel
Doucette, John T.
Liu, Jerry
Chadha, Manjeet
Kalir, Tamara
Gupta, Vishal
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (05) : 882 - 889
[22] Heterogeneity of patients with high-intermediate and high-risk endometrial cancer included in prospective trials
Praiss, A. M.
Huang, Y.
Collado, F. Khoury
Tergas, A. I.
Melamed, A.
Hou, J. Y.
St Clair, C. M.
Wright, J. D.
GYNECOLOGIC ONCOLOGY, 2020, 159 : 69 - 70
[23] Adjuvant docetaxel and carboplatin chemotherapy for patients with high-intermediate and high-risk endometrial cancer
Kudaka, W.
Nakasone, T.
Arakaki, Y.
Nakamoto, T.
Wakayama, A.
Kinjyo, Y.
Taira, Y.
Nagai, Y.
Kaneshima, I.
Nishihira, K.
Aoki, Y.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (06) : 917 - 920
[24] Hereditary Cancer Syndromes with High Risk of Endometrial and Ovarian Cancer: Surgical Options for Personalized Care
McCann, Georgia A.
Eisenhauer, Eric L.
JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (01) : 118 - 124
[25] Is lymphadenectomy necessary for high-risk penile cancer?
Drake R.
Nature Reviews Urology, 2010, 7 (10) : 532 - 532
[26] OCCULT, HIGH-RISK ENDOMETRIAL CANCER
SMITH, M
MCCARTNEY, AJ
GYNECOLOGIC ONCOLOGY, 1985, 22 (02) : 154 - 161
[27] Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker
Backes, Floor J.
Haag, Jennifer
Cosgrove, Casey M.
Suarez, Adrian
Cohn, David E.
Goodfellow, Paul J.
CANCER, 2019, 125 (03) : 398 - 405
[28] Lymphadenectomy for high-risk endometrial cancer: Does it impact lymph node recurrence?
Swift, B. E.
Philp, L.
Atenafu, E. G.
Malkani, N.
Gien, L. T.
Bernardini, M. Q.
GYNECOLOGIC ONCOLOGY, 2020, 159 : 69 - 69
[29] Comparison of three surgical approaches for staging lymphadenectomy in high-risk endometrial cancer
Pulman, Katherine J.
Dason, Ebernella S.
Philp, Lauren
Bernardini, Marcus Q.
Ferguson, Sarah E.
Laframboise, Stephane
Atenafu, Eshetu G.
May, Taymaa
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 136 (03) : 315 - 319
[30] Lymphadenectomy Should Be Performed Up to the Renal Vein in Patients with Intermediate-High Risk Endometrial Cancer
Alay, Ismail
Turan, Taner
Ureyen, Isin
Karalok, Alper
Tasci, Tolga
Ozfuttu, Ahmet
Kose, M. Faruk
Tulunay, Gokhan
PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (03) : 803 - 810

← 1 2 3 4 5 →